Tekmira Pharmaceuticals Corporation
(604) 419-3200
Contact and Address
| Category: | Health, |
|---|---|
| Address: | 8900 Glenlyon Pkwy, Burnaby, BC V5J 5J8, Canada |
| Postal code: | V5J 5J8 |
| Phone: | (604) 419-3200 |
| Website: | http://www.tekmira.com/ |
Location & routing
Most Recent Reviews
(June 4, 2018, 3:01 am)awesome customer service.
Photos of Tekmira Pharmaceuticals Corporation
Tekmira Pharmaceuticals Corporation On the Web
Tekmira Pharmaceuticals Corporation - Hours & Reviews - 8900 ...
Tekmira Pharmaceuticals Corporation - Health clinic in Burnaby, BC - 8900 Glenlyon Parkway, Burnaby, British Columbia. Read verified and trustworthy customer reviews for Tekmira Pharmaceuticals Corporation or write your own review.
Tekmira Announces Launch of Arbutus Biopharma, a Hepatitis B ...
Tekmira Announces Launch of Arbutus Biopharma, a Hepatitis B Solutions Company ... Tekmira Pharmaceuticals Corporation is a biopharmaceutical company dedicated to discovering, developing and ...
Tekmira Pharmaceuticals Corporation Investments
+1 604 419-3200 Fax : +1 604 419-3201 ... Tekmira Pharmaceuticals Corporation Investments Show Current Show All . Segmented By Countries
Arbutus Biopharma Corp 8-K Jan 21 2015 | Seeking Alpha
Arbutus Biopharma Corp (ABUS) FORM 8-K ... Tekmira Pharmaceuticals Corporation ... (604) 419-3200 _____ (Former name or former address, if changed since last report) Check the appropriate box ...
Tekmira Pharmaceuticals Provides Corporate Update | FierceBiotech
Tekmira Pharmaceuticals Provides Corporate UpdateFor immediate release: ... 2010 VANCOUVER, BC - Tekmira Pharmaceuticals Corporation (TSX: TKM), a leader in RNA interference (RNAi) ... 604-419-3200 .
Tekmira Initiates Phase I Clinical Trial Of TKM-HBV | BioSpace
The Annual Report on Form 10-K and other public filings are available free of charge through the SEC's website at www.sec.gov and from Tekmira by contacting Investor Relations by telephone at (604) 419-3200 or upon written request addressed to our corporate secretary at Tekmira Pharmaceuticals Corporation, Tekmira Pharmaceuticals Corporation ...
Arbutus Biopharma Corp DEFA14A Feb 5 2015 | Seeking Alpha
Arbutus Biopharma Corp (ABUS) ... On January 31, 2015, the board of directors (the "Board") of Tekmira Pharmaceuticals Corporation (the "Company") adopted a quorum policy to be applied to ...
Tekmira Pharmaceuticals and Protiva Biotherapeutics Announce ...
VANCOUVER, BRITISH COLUMBIA--(Marketwire - June 2, 2008) - Tekmira Pharmaceuticals Corporation ("Tekmira") (TSX:TKM) and Protiva Biotherapeutics Inc. ("Protiva") announced today that they have ...
Arbutus Biopharma (NASDAQ: ABUS) Finalizes Corporate Name ...
Arbutus Biopharma (NASDAQ: ABUS) Finalizes Corporate Name Change From Tekmira Pharmaceuticals
S-3
TEKMIRA PHARMACEUTICALS CORPORATION (Exact name of registrant as specified in its charter) British Columbia : Not Applicable (State or other jurisdiction of.